The global rheumatoid arthritis drugs market reached a value of USD 24.89 billion in 2022 and is projected to reach USD 38.61 billion by 2032, with a forecasted revenue compound annual growth rate (CAGR) of 5%. Rheumatoid arthritis is a chronic autoimmune disease that causes joint inflammation and discomfort. Its prevalence is increasing worldwide, with approximately 1.3 million people affected in the United States alone. This rise in prevalence can be attributed to factors such as an aging population, changing lifestyles.
https://www.reportsanddata.com..../report-detail/rheum
Like
Comment
Share
